SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950005-03-001227
Filing Date
2003-12-15
Accepted
2003-12-15 17:29:46
Documents
4
Period of Report
2003-12-11
Items
Item 4: Changes in registrant's certifying accountant
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT p18018_8k.txt 8-K 3539
3 PRESS RELEASE p18018_ex99-01.txt EX-99.01 1254
4 PRESS RELEASE p18018_ex99-02.txt EX-99.02 2800
5 PRESS RELEASE p18018_ex99-03.txt EX-99.03 2621
  Complete submission text file 0000950005-03-001227.txt   12233
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26372 | Film No.: 031055524
SIC: 2834 Pharmaceutical Preparations